Opera S 500 mg/250 mg Injection
By Opera S
Rx
1ml Injection in a Vial

Composition
Ceftriaxone(500mg) + Sulbactam(250mg)

Manufacturer - Clyde Biotech P Ltd
33, SHANTI KUNJ HOUSING CO-OPERATIVE SOCIETY OPP. INDIAN OIL PETROL PUMP, ANISABAD-PHULWARI RD PATNA BR 801505 IN , - , .

Expires on or after
October, 2025

liver
Caution should be exercised when using Opera S 500 mg/250 mg Injection in patients with severe liver disease. It may be necessary to adjust the dosage of Opera S 500 mg/250 mg Injection in these cases, so it is important to consult your doctor for guidance before use. However, dose adjustment is generally not advised for patients with mild to moderate liver disease. It's crucial to consider these factors regarding liver health when using Opera S 500 mg/250 mg Injection to ensure safe and effective treatment.

kidney
Consult your healthcare provider regarding the use of Opera S 500 mg/250 mg Injection if you have kidney disease. Limited information is available on its safety in such patients.

alcohol
When using Opera S 500 mg/250 mg Injection, it is safe to consume alcohol as it does not result in any harmful side effects.

driving
When using Opera S 500 mg/250 mg Injection, be cautious as it may reduce alertness, impact vision, or cause drowsiness and dizziness. Avoid driving if experiencing these effects.

pregnancy
Opera S 500 mg/250 mg Injection is usually safe during pregnancy based on animal studies. Limited human studies available.

breastfeeding
During breastfeeding, it is advised to use Opera S 500 mg/250 mg Injection with caution. It is recommended to pause breastfeeding until the treatment is finished and the medication is no longer in the mother's system.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | ANTI INFECTIVES |
Action Class | - |
₹80.4
Inclusive of all taxes
Content verified by

Dr. Archana Prabhakar
MBBS, M.Med (Family Medicine)
Last update on 11-Feb-2025